• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂性水肿相关疼痛的病因和处理。

Cause and management of lipedema-associated pain.

机构信息

Department of Dermatology, Istanbul Medeniyet University, School of Medicine, Goztepe Training and Research Hospital, Istanbul, Turkey.

Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital of the Technical University, Dresden, Germany.

出版信息

Dermatol Ther. 2021 Jan;34(1):e14364. doi: 10.1111/dth.14364. Epub 2020 Oct 12.

DOI:10.1111/dth.14364
PMID:33001552
Abstract

Lipedema is a painful, underdiagnosed adipose tissue disorder, characterized by symmetrical swelling of the extremities due to subcutaneous fat deposition in the buttocks, thighs, legs, and arms, sparing the most distal part of the extremities. Although etiology and pathogenesis of lipedema is unclear, possible role of hormonal and genetic factors have been proposed previously. Patients with lipedema suffer from pain, easy bruising, tenderness, and disfigurement. Pain is the leading symptom in lipedema. Since the pain is associated with depression and impaired quality of life, reduction of pain is the major therapeutic approach. Pain in lipedema is attributed to allodynia, exaggerated sympathetic signaling, and estrogens. Although the mechanism of pain in lipedema is uncertain, effective treatment of lipedema should provide a satisfactory pain reduction. Efficacy of the conservative treatment is a matter of debate. Microcannular tumescent liposuction is the most effective therapeutic option for lipedema. There is a large body of evidence that this procedure significantly reduces pain in patients with lipedema.

摘要

脂肪水肿是一种疼痛性、诊断不足的脂肪组织疾病,其特征为臀部、大腿、小腿和手臂的皮下脂肪沉积导致四肢对称性肿胀,而四肢最远端未受累。尽管脂肪水肿的病因和发病机制尚不清楚,但先前已经提出了激素和遗传因素的可能作用。脂肪水肿患者会出现疼痛、容易瘀伤、压痛和畸形。疼痛是脂肪水肿的主要症状。由于疼痛与抑郁和生活质量受损有关,因此减轻疼痛是主要的治疗方法。脂肪水肿的疼痛归因于感觉过敏、交感神经信号过度放大和雌激素。尽管脂肪水肿疼痛的机制尚不清楚,但有效的脂肪水肿治疗应该能提供令人满意的疼痛缓解。保守治疗的疗效存在争议。微创肿胀吸脂术是治疗脂肪水肿最有效的治疗选择。有大量证据表明,该手术可显著减轻脂肪水肿患者的疼痛。

相似文献

1
Cause and management of lipedema-associated pain.脂性水肿相关疼痛的病因和处理。
Dermatol Ther. 2021 Jan;34(1):e14364. doi: 10.1111/dth.14364. Epub 2020 Oct 12.
2
[Lipedema: up-to-date of a long forgotten disease].[脂肪性水肿:一种被长期遗忘疾病的最新情况]
Wien Med Wochenschr. 2017 Oct;167(13-14):343-348. doi: 10.1007/s10354-017-0566-2. Epub 2017 May 10.
3
Treatment of lipedema by low-volume micro-cannular liposuction in tumescent anesthesia: Results in 111 patients.肿胀麻醉下小容量微管吸脂术治疗脂肪水肿:111 例患者的结果。
Dermatol Ther. 2019 Mar;32(2):e12820. doi: 10.1111/dth.12820. Epub 2019 Jan 30.
4
Prevention of Progression of Lipedema With Liposuction Using Tumescent Local Anesthesia: Results of an International Consensus Conference.《肿胀局麻吸脂术预防脂肪水肿进展:国际共识会议结果》。
Dermatol Surg. 2020 Feb;46(2):220-228. doi: 10.1097/DSS.0000000000002019.
5
6
Lipedema-An update.脂肪水肿——最新进展。
Dermatol Ther. 2019 Mar;32(2):e12805. doi: 10.1111/dth.12805. Epub 2018 Dec 27.
7
A randomised controlled multicentre investigator-blinded clinical trial comparing efficacy and safety of surgery versus complex physical decongestive therapy for lipedema (LIPLEG).一项比较手术与复杂物理消肿疗法治疗脂肪水肿(LIPLEG)疗效和安全性的随机对照多中心研究者盲法临床试验。
Trials. 2021 Oct 30;22(1):758. doi: 10.1186/s13063-021-05727-2.
8
S1 guidelines: Lipedema.S1 指南:脂肪水肿。
J Dtsch Dermatol Ges. 2017 Jul;15(7):758-767. doi: 10.1111/ddg.13036.
9
[Recognising and treating lipidema OMIM 614103].[认识和治疗脂肿病(OMIM 614103)]
Ann Dermatol Venereol. 2015 Aug-Sep;142(8-9):523-9. doi: 10.1016/j.annder.2015.06.011. Epub 2015 Aug 6.
10
A Case Series of Lymphatic Injuries After Suction Lipectomy in Women with Lipedema.脂肪营养不良女性吸脂术后淋巴管损伤的病例系列
Am J Case Rep. 2022 Jul 11;23:e935016. doi: 10.12659/AJCR.935016.

引用本文的文献

1
The ıncidence of neuropathic pain and ıts ımpact on quality of life in patients with lipedema.脂肪性水肿患者中神经性疼痛的发生率及其对生活质量的影响。
Ir J Med Sci. 2025 Aug 11. doi: 10.1007/s11845-025-04024-0.
2
Mental and physical health burden and quality of life in Czech women with lipedema.患有脂肪性水肿的捷克女性的身心健康负担及生活质量
Front Glob Womens Health. 2025 Jul 24;6:1629077. doi: 10.3389/fgwh.2025.1629077. eCollection 2025.
3
A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with Exenatide.
脂肪性水肿药物治疗疗效的病例系列:意大利使用艾塞那肽的经验
Clin Pract. 2025 Jul 7;15(7):128. doi: 10.3390/clinpract15070128.
4
Therapeutic Applications of Ketogenic Diets in Lipedema: A Narrative Review of Current Evidence.生酮饮食在脂肪性水肿中的治疗应用:当前证据的叙述性综述
Curr Obes Rep. 2025 May 26;14(1):49. doi: 10.1007/s13679-025-00642-y.
5
Lipedema: Clinical Features, Diagnosis, and Management.脂肪性水肿:临床特征、诊断与管理
Arch Plast Surg. 2025 May 15;52(3):185-196. doi: 10.1055/a-2530-5875. eCollection 2025 May.
6
Chromium and formoterol therapy for obesity-induced asthma in rats.铬与福莫特罗对大鼠肥胖诱导型哮喘的治疗作用
Front Pharmacol. 2025 Apr 2;16:1537022. doi: 10.3389/fphar.2025.1537022. eCollection 2025.
7
Physiotherapy Intervention in the Immediate Postoperative Phase of Lipedema Surgery-Observational Study.脂肪水肿手术术后即刻阶段的物理治疗干预——观察性研究
J Clin Med. 2025 Mar 21;14(7):2137. doi: 10.3390/jcm14072137.
8
Changes in Cytokines and Fibrotic Growth Factors after Low-Carbohydrate or Low-Fat Low-Energy Diets in Females with Lipedema.低脂血症女性采用低碳水化合物或低脂低能量饮食后细胞因子和纤维化生长因子的变化
Curr Dev Nutr. 2025 Feb 20;9(3):104571. doi: 10.1016/j.cdnut.2025.104571. eCollection 2025 Mar.
9
Brazilian Consensus Statement on Lipedema using the Delphi methodology.采用德尔菲法的巴西脂肪性水肿共识声明。
J Vasc Bras. 2025 Feb 10;24:e20230183. doi: 10.1590/1677-5449.202301832. eCollection 2025.
10
The Efficacy of Ketogenic Diets (Low Carbohydrate; High Fat) as a Potential Nutritional Intervention for Lipedema: A Systematic Review and Meta-Analysis.生酮饮食(低碳水化合物;高脂肪)作为脂性水肿的一种潜在营养干预措施的疗效:系统评价和荟萃分析。
Nutrients. 2024 Sep 27;16(19):3276. doi: 10.3390/nu16193276.